Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. SLRN.NASDAQ

ACELYRIN INC. Common Stock (SLRN NASDAQ) stock market data APIs

$6.84 -0.16(-2.3%) as of July 26, 2024
Price chart is built with Anychart

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.

ACELYRIN INC. Common Stock Financial Data Overview

7
6.84
-
7.1
6.701
3.67-29.88
693 M
99 027 K
0
-0.36
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SLRN',
Type: 'Common Stock',
Name: 'ACELYRIN INC. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YJKJ8H4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1962918',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-05-04',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

ACELYRIN INC. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -288 292 000
  • Earnings Per Share -2.43
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get ACELYRIN INC. Common Stock Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -0.98

Get ACELYRIN INC. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get ACELYRIN INC. Common Stock latest news via APIs

Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?

Buy low, sell high. It’s an investing mantra drummed into our heads from the moment we start buying stocks. But it’s not easy to do. When our stocks start falling, the first inclination for many i...

DEADLINE ALERT for SKIN, SMR, SLRN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-trade...
  • CLASS ACTION
  • LAW & LEGAL ISSUES
Do you have any questions?
support@eodhistoricaldata.com